Prognostic Factors in Adrenocortical Carcinoma: The Added Value of CT-Based Imaging Biomarkers

Abstract

Get full access to this article

View all access options for this article.

References

Yalon

Assaf

, et al. Differentiating between adrenocortical carcinoma and lipid-poor cortical adenoma: a novel cross-sectional imaging-based score. Surgery. 2023;173(1):35-42. doi:10.1016/j.surg.2022.07.029

Ahmed

Elmohr

Fuentes

, et al. Radiomic mapping model for prediction of Ki-67 expression in adrenocortical carcinoma. Clin Radiol. 2020;75(6):479.e17-479.e22. doi:10.1016/j.crad.2020.01.012

Libé

Borget

Ronchi

, et al. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. Ann Oncol. 2015;26(10):2119-2125. doi:10.1093/annonc/mdv329

Barat

Eltaher

Moawad

, et al. A computed tomography-based score to predict survival in patients with adrenocortical carcinoma: a proof-of-concept study. Can Assoc Radiol J. Published online May 4, 2025. doi:10.1177/08465371251335170

Shariq

McKenzie

. Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment. Ther Adv Chronic Dis. Published online July 20, 2021. doi:10.1177/20406223211033103